Q2pharma specializes in developing small-molecule drugs against multi-drug resistant (MDR) bacteria to be used in conjunction with commonly used antibiotics or as stand-alone medications.
Our lead compound, F19 has shown promise in combating deadly MDR bacterial infections. Whereas antibiotics kill bacteria, as an antivirulent, F19 inhibits bacterial toxin release and thus, stops the bacterial attack, allowing the immune system to do its job more effectively. F19 has been shown to potentiate antibiotic efficacy, even to antibiotics that the pathogen is otherwise resistant. Recent experiments have demonstrated F19’s potent effects on several of the most common and deadly MDR bacteria.
Company Details
- Employees
- 1
- Founded
- -
- Address
- 24 Ben-Gurion Blvd., Haifa,israel 31000,israel
- Phone
- +972-52-5984109
- in****@****rma.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- q2pharma.com
- Keywords
- Bacteriology, Small-molecule drug development, Pre-clinical research, MRSA, Clinical trials, Pharmacology, Multi-drug resistant bacteria, Anti-Virulence, C. Diff, Infectious disease.
- HQ
- Haifa, Israel
Q2pharma Questions
Q2Pharma's helpline number is +972-52-5984109
Q2Pharma's website is q2pharma.com
Q2Pharma's LinkedIn profile is https://il.linkedin.com/company/q2pharma
Q2Pharma has
1 employees.
View email and phone details for 1
employees at Q2Pharma.
Q2Pharma's industry is
Pharmaceutical Manufacturing
Q2Pharma's top competitors are
Vessl Therapeutics,
Bacfarm,
Turbulent Technologies,
Facense Ltd.,
Rise Nano Optics Ltd,
Sphinx Smarthead Technologies,
Bactusense Technologies,
Safesac Medical,
Bactobyte Ltd,
Vgtest.
Q2Pharma's support email address is info@q2pharma.com
Q2Pharma's categories are Pharmaceutical Manufacturing
Q2Pharma's founding year is 2015
